Related references
Note: Only part of the references are listed.Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient
Deborah Eshagh et al.
INFECTION (2020)
Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis Case report and review
Miguel Santin et al.
MEDICINE (2020)
Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
Zheng Zhang et al.
BMJ OPEN (2017)
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS
Denise C. Hsu et al.
CLINICAL INFECTIOUS DISEASES (2016)
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
Shruthi Ravimohan et al.
CLINICAL INFECTIOUS DISEASES (2016)
Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS
Clemence Richaud et al.
AIDS (2015)
Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction
James S. Molton et al.
MEDICAL JOURNAL OF AUSTRALIA (2015)
Clinical Response to Thalidomide in the Treatment of Intracranial Tuberculomas: Case Report
Patricia de la Riva et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS
Anne-Sophie Brunel et al.
AIDS (2012)
Reversion of cerebral artery stenoses due to tuberculomas with TNF-α antibodies
Stefaan J. Vandecasteele et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients
G. Breton et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
A Life-Threatening Central Nervous System-Tuberculosis Inflammatory Reaction Nonresponsive to Corticosteroids and Successfully Controlled by Infliximab in a Young Patient With a Variant of Juvenile Idiopathic Arthritis
Jaimes-Hernandez Jorge et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2012)
Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis
Ho-Su Lee et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Mycobacterium kansasii cutaneous abscesses occurring as immune reconstitution inflammatory syndrome
Elizabeth Connick et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
Graeme Meintjes et al.
AIDS (2010)
Adalimumab Treatment of Life-Threatening Tuberculosis
Robert S. Wallis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Timothy K. Blackmore et al.
CLINICAL INFECTIOUS DISEASES (2008)
The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports
MTM Roberts et al.
JOURNAL OF INFECTION (2003)
Immune reconstitution inflammatory syndrome - Emergence of a unique syndrome during highly active antiretroviral therapy
SA Shelburne et al.
MEDICINE (2002)